GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: P3A | SYN-004
Compound class:
Peptide
Comment: Ribaxamase is an orally delivered β-lactamase enzyme, under clinical development as a protective agent against dysbiosis of the gastrointestinal tract caused by some antibacterial drugs [1]. The peptide sequence for ribaxamase is available from its INN record.
|
Classification ![]() |
|
| Compound class | Peptide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10447 | ribaxamase |
Synonyms ![]() |
| P3A | SYN-004 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Ribaxamase |
| Other databases | |
| CAS Registry No. | 1792207-66-9 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL3989985 |
| DrugBank Ligand | DB16311 |
| Search PubMed clinical trials | ribaxamase |
| Search PubMed titles | ribaxamase |
| Search PubMed titles/abstracts | ribaxamase |